Saturday, December 14

Healthcare

Soleno lead asset granted FDA priority review

08/27/20241 Min Read

asset FDA granted lead priority review Soleno

Previous ArticleEnsysce wins $14M federal grant for lead pain therapy

Next Article Eli Lilly Zepbound low-dose price cut by 50% (NYSE:LLY)